Compound_ID |
Target |
Gene_Name |
Gene_ID |
Cancer |
Cell_lines |
IC50 Value |
EC50 Value |
ED50 Value |
GI50 Value |
Remarks |
References |
MMP-AC0097 |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
836 |
Breast Carcinoma |
MDA-MB-231 |
- |
- |
- |
- |
Costunolide suppresses cell growth in MDA-MB-231 breast cancer cells through extrinsic-apoptotic pathway related with activation of Caspase-3. |
22147197 |
MMP-AC0097 |
ASP8 |
caspase 8, apoptosis-related cysteine peptidase |
841 |
Breast Carcinoma |
MDA-MB-231 |
- |
- |
- |
- |
costunolide suppresses cell growth in MDA-MB-231 breast cancer cells through extrinsic-apoptotic pathway related with activation of caspase-8. |
22147197 |
MMP-AC0097 |
CCNB1 |
cyclin B1 |
891 |
Breast Carcinoma |
MDA-MB-231 |
- |
- |
- |
- |
Costunolide treatment resulted in a decrease in the levels of central protein for G2/M transition such as Cdc2 and cyclin B. |
22147197 |
MMP-AC0097 |
CDK1 |
cyclin-dependent kinase 1 |
983 |
Breast Carcinoma |
MDA-MB-231 |
- |
- |
- |
- |
Costunolide treatment resulted in a decrease in the levels of central protein for G2/M transition such as Cdc2. |
22147197 |
MMP-AC0097 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 |
Breast Carcinoma |
MDA-MB-231 |
- |
- |
- |
- |
Costunolide-induced G2/M cell cycle arrest is associated with upregulation of p21WAF1 in MDA-MB-231 cells through a p53-independent pathway. |
22147197 |
MMP-AC0097 |
Fas |
TNF receptor superfamily, member 6 |
355 |
Breast Carcinoma |
MDA-MB-231 |
- |
- |
- |
- |
costunolide suppresses cell growth in MDA-MB-231 breast cancer cells through extrinsic-apoptotic pathway related with activation of Fas-death receptor. |
22147197 |
MMP-AC0097 |
PARP1 |
poly (ADP-ribose) polymerase 1 |
142 |
Breast Carcinoma |
MDA-MB-231 |
- |
- |
- |
- |
we found that the cleavage of PARP was inhibited after 24-h incubation while costunolide alone still shows the degradation of PAR. |
22147197 |